MYALEPTA
MYALEPTA
Approved
DIN Number
02544571
Drug Class
Human
Market Date
Jun 26, 2024
Company
HC
CHIESI FARMACEUTICI S.P.A.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02544571
AIG Number0165662003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AA07 METRELEPTIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification68:40.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
METRELEPTINActive
Strength: 11.3 MG / VIAL
Monograph: METRELEPTIN